Senseonics Holdings, Inc.
SENSSenseonics Holdings, Inc. in brief
Senseonics Holdings, Inc. is a listed company in the Healthcare sector, based in Germantown, Maryland, USA. Its market value was $506 M on 13 October 2026, which makes it the 12,501st largest listed company in the world and the 2,524th largest in the USA on this site. In the year to December 2025 it had sales of $35 M and a net loss of $69 M. It employs about 130 people and Timothy T. Goodnow is its chief executive. Its largest business segments by sales in 2025 were Single reportable segment (100%). By market, the largest shares of its 2025 sales came from USA (79%). Its shares trade under the symbol SENS (Nasdaq).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Senseonics Holdings, Inc.
We are a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Our implantable CGM system, including Eversense E3 and Eversense 365 CGM systems are designed to continually and accurately measure glucose levels in people with diabetes via an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to twelve months in the case of Eversense 365 and six months in the case of Eversense E3, as compared to seven to 15 days for non-implantable CGM systems. In September 2024, the 365-day extended life Eversense E3 CGM system was approved by the FDA and, through Ascensia Diabetes Care Holdings AG, we began commercializing Eversense 365 in the fourth quarter of 2024. In January 2026, we took over full commercial responsibility for Eversense 365 in the United States and began marketing and distributing the product with our own sales force. In June 2022, we affixed the CE Mark to the Eversense E3 CGM system and Ascensia began commercialization in select markets in Europe during the third quarter of 2022. In January 2026, the Company obtained CE Mark approval for Eversense 365 and expects to launch Eversense 365 in the European Territories by the second half of 2026.
From the company's annual report filed with the US SEC: read the report
Senseonics Holdings, Inc. timeline
- 2014
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
- 2015
- ✎Renamed Senseonics Holdings, Inc.Formerly ASN Technologies, Inc..
- 2016
- 🔔Initial public offeringFinal prospectus filed with the SEC on 18 March 2016; shares registered for exchange trading on 11 March 2016.
- 2025
- 💰Record revenue of $35 millionFY2025, the highest of the 8 years on record.
Events of Senseonics Holdings, Inc. from SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in USA: #2,625 (Dec 2022) · #2,832 (Jul 2023) · #2,978 (Jan 2024) · #1,605 (Mar 2026) · #2,647 (Aug 2026) · #2,522 (Oct 2026)
Key ratios
- P/E ratio (TTM)
- n/m (loss)
- Price / sales (TTM)
- 8.4×
- Price / book
- 8.3×
- Free cash flow yield
- -11.9%
- Net margin (TTM)
- -204.2%
- Operating margin
- -193.8%
- Return on equity
- -200.7%
- Liabilities / assets
- 51.7%
- Net debt
- $-5M
- Revenue growth
- +56.9%
- R&D / revenue
- 89.6%
- Revenue per employee
- $271 K
- Profit per employee
- $-532 K
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $35M | +56.9% | $-68M | $-69M | -196.0% |
| Dec 2024 | $22M | +0.4% | $-75M | $-79M | -349.9% |
| Dec 2023 | $22M | +36.6% | $-76M | $-60M | -269.7% |
| Dec 2022 | $16M | +19.8% | $-69M | $142M | 867.1% |
| Dec 2021 | $14M | +176.4% | $-57M | $-302M | -2211.0% |
| Dec 2020 | $5M | -76.8% | $-79M | $-175M | -3538.8% |
| Dec 2019 | $21M | +12.6% | $-131M | $-116M | -542.5% |
| Dec 2018 | $19M | — | $-88M | $-94M | -496.9% |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Dec 2025 | $-59M | $1M | $-60M | $-1.66 | — |
| Dec 2024 | $-60M | $2M | $-63M | $-2.50 | — |
| Dec 2023 | $-70M | $0M | $-71M | $-0.11 | — |
| Dec 2022 | $-66M | $0M | $-67M | $-0.11 | — |
| Dec 2021 | $-56M | $0M | $-56M | $-0.72 | — |
| Dec 2020 | $-67M | $0M | $-68M | $-0.77 | — |
| Dec 2019 | $-136M | $1M | $-137M | $-0.61 | — |
| Dec 2018 | $-91M | $1M | $-92M | $-0.60 | — |
Quarterly results
Latest quarter to Sep 2026: revenue $20M (+141.5% on a year earlier), net income $-33M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.
SEC filings
- Nov 9, 202610-QQuarterly report · period to Sep 2026
- Nov 9, 20268-KCurrent reportResults of operations
- Aug 6, 202610-QQuarterly report · period to Jun 2026
- Aug 6, 20268-KCurrent reportResults of operations
- Jun 8, 20268-KCurrent reportOther events
- May 20, 20268-KCurrent reportBylaws amended · Shareholder vote
- May 7, 202610-QQuarterly report · period to Mar 2026
- May 7, 20268-KCurrent reportResults of operations
- May 4, 20268-KCurrent reportMaterial agreement · New financial obligation
- May 1, 20268-KCurrent reportMaterial agreement · Results of operations · Regulation FD disclosure · Other events
- Apr 6, 2026DEF 14AProxy statement
- Mar 12, 20268-KCurrent reportMaterial agreement
Official filings of Senseonics Holdings, Inc. with the US Securities and Exchange Commission.
Annual results
- Revenue
- $35 M
- Operating income
- $-68 M
- Net income
- $-69 M
For year ending December-2025 · source: SEC filing
Balance sheet
- Total assets
- $126 M
- Total liabilities
- $65 M
- Total equity
- $61 M
As of December-2025
Top 100 institutional investors in Senseonics Holdings, Inc.#
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 1 | Sessa Capital IM, L.P. | 4,437,532 | 0 (0.00%) | 8.10% | $45 M | Nov 16, 2026 |
| 2 | BlackRock, Inc. | 2,826,616 | +33,058 (+1.18%) | 5.16% | $29 M | Nov 13, 2026 |
| 3 | Sio Capital Management, LLC | 2,290,860 | +698,168 (+43.84%) | 4.18% | $23 M | Nov 16, 2026 |
| 4 | Vanguard Capital Management LLC | 2,209,838 | +430,440 (+24.19%) | 4.03% | $22 M | Nov 13, 2026 |
| 5 | Geode Capital Management, LLC | 1,123,625 | -8,585 (-0.76%) | 2.05% | $11 M | Nov 6, 2026 |
| 6 | UBS Group AG | 976,929 | -510,500 (-34.32%) | 1.78% | $10 M | Nov 10, 2026 |
| 7 | State Street Corp | 954,684 | +443,567 (+86.78%) | 1.74% | $10 M | Nov 12, 2026 |
| 8 | Masters Capital Management LLC | 800,000 | +100,000 (+14.29%) | 1.46% | $8 M | Nov 16, 2026 |
| 9 | Walleye Capital LLC | 701,290 | +377,026 (+116.27%) | 1.28% | $7 M | Nov 13, 2026 |
| 10 | Millennium Management LLC | 655,447 | +576,229 (+727.40%) | 1.20% | $7 M | Nov 16, 2026 |
| 11 | Bank Of America Corp /de/ | 551,394 | +156,929 (+39.78%) | 1.01% | $6 M | Nov 16, 2026 |
| 12 | Charles Schwab Investment Management Inc | 420,339 | +27,128 (+6.90%) | 0.77% | $4 M | Nov 16, 2026 |
| 13 | Marshall Wace, LLP | 395,181 | -10,514 (-2.59%) | 0.72% | $4 M | Nov 13, 2026 |
| 14 | Trexquant Investment LP | 387,586 | +252,458 (+186.83%) | 0.71% | $4 M | Nov 16, 2026 |
| 15 | Jpmorgan Chase & Co | 385,347 | +367,775 (+2092.96%) | 0.70% | $4 M | Nov 12, 2026 |
| 16 | Nuveen, LLC | 383,566 | +331,433 (+635.75%) | 0.70% | $4 M | Nov 10, 2026 |
| 17 | Goldman Sachs Group Inc | 371,706 | +140,197 (+60.56%) | 0.68% | $4 M | Nov 16, 2026 |
| 18 | Vanguard Fiduciary Trust Co | 332,386 | +1,033 (+0.31%) | 0.61% | $3 M | Nov 13, 2026 |
| 19 | Northern Trust Corp | 325,009 | -7,257 (-2.18%) | 0.59% | $3 M | Nov 16, 2026 |
| 20 | Vanguard Portfolio Management LLC | 263,272 | -9,103 (-3.34%) | 0.48% | $3 M | Nov 13, 2026 |
| 21 | AQR Capital Management LLC | 248,060 | New | 0.45% | $3 M | Nov 16, 2026 |
| 22 | Invesco Ltd. | 195,407 | +158,471 (+429.04%) | 0.36% | $2 M | Nov 12, 2026 |
| 23 | Morgan Stanley | 160,319 | -4,665 (-2.83%) | 0.29% | $2 M | Nov 13, 2026 |
| 24 | BNP Paribas Financial Markets | 153,292 | +93,591 (+156.77%) | 0.28% | $2 M | Nov 12, 2026 |
| 25 | HRT Financial LP | 136,132 | New | 0.25% | $1 M | Nov 13, 2026 |
Show all 100: investors 26 to 100
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 26 | Citadel Advisors LLC | 129,726 | +95,934 (+283.90%) | 0.24% | $1 M | Nov 16, 2026 |
| 27 | Russell Investments Group, Ltd. | 110,532 | -42,684 (-27.86%) | 0.20% | $1 M | Nov 6, 2026 |
| 28 | Avidity Partners Management LP | 100,000 | -1,500,000 (-93.75%) | 0.18% | $1 M | Nov 16, 2026 |
| 29 | Bank of New York Mellon Corp | 90,612 | +6,129 (+7.25%) | 0.17% | $1 M | Nov 5, 2026 |
| 30 | Penn Capital Management Company, LLC | 75,695 | -18,445 (-19.59%) | 0.14% | $1 M | Nov 4, 2026 |
| 31 | Two Sigma Investments, LP | 72,733 | +54,402 (+296.78%) | 0.13% | $1 M | Nov 16, 2026 |
| 32 | Simplex Trading, LLC | 71,680 | +70,330 (+5209.63%) | 0.13% | $1 M | Nov 4, 2026 |
| 33 | SEI Investments Co | 68,928 | -16,810 (-19.61%) | 0.13% | $1 M | Nov 10, 2026 |
| 34 | Bridgeway Capital Management, LLC | 67,261 | -1,039 (-1.52%) | 0.12% | $1 M | Nov 16, 2026 |
| 35 | Empowered Funds, LLC | 61,061 | New | 0.11% | $1 M | Nov 13, 2026 |
| 36 | Citigroup Inc | 56,314 | +37,518 (+199.61%) | 0.10% | $1 M | Nov 4, 2026 |
| 37 | Squarepoint Ops LLC | 54,732 | +43,576 (+390.61%) | 0.10% | $1 M | Nov 9, 2026 |
| 38 | Barclays PLC | 53,768 | +45,133 (+522.68%) | 0.10% | $1 M | Nov 6, 2026 |
| 39 | PDT Partners, LLC | 52,442 | New | 0.10% | $1 M | Nov 16, 2026 |
| 40 | Tocqueville Asset Management L.P. | 51,550 | -3,950 (-7.12%) | 0.09% | $1 M | Nov 13, 2026 |
| 41 | Price T Rowe Associates Inc /MD/ | 51,275 | 0 (0.00%) | 0.09% | $1 M | Nov 16, 2026 |
| 42 | Ghisallo Capital Management LLC | 50,000 | -75,000 (-60.00%) | 0.09% | $1 M | Nov 16, 2026 |
| 43 | Rhumbline Advisers | 42,462 | -328 (-0.77%) | 0.08% | $0 M | Nov 10, 2026 |
| 44 | IMC-Chicago, LLC | 37,626 | New | 0.07% | $0 M | Nov 5, 2026 |
| 45 | GMT Capital Corp | 36,468 | 0 (0.00%) | 0.07% | $0 M | Nov 16, 2026 |
| 46 | Deutsche Bank AG\ | 34,467 | -4,793 (-12.21%) | 0.06% | $0 M | Nov 6, 2026 |
| 47 | XTX Topco Ltd | 33,873 | New | 0.06% | $0 M | Nov 16, 2026 |
| 48 | Symmetry Partners, LLC | 26,032 | +1,159 (+4.66%) | 0.05% | $0 M | Oct 27, 2026 |
| 49 | Fox Run Management, L.L.C. | 25,943 | -44,955 (-63.41%) | 0.05% | $0 M | Nov 12, 2026 |
| 50 | Boothbay Fund Management, LLC | 25,896 | New | 0.05% | $0 M | Nov 16, 2026 |
| 51 | Pathstone Holdings, LLC | 25,154 | +154 (+0.62%) | 0.05% | $0 M | Nov 13, 2026 |
| 52 | Dimensional Fund Advisors LP | 21,741 | -12,896 (-37.23%) | 0.04% | $0 M | Nov 4, 2026 |
| 53 | Ieq Capital, LLC | 21,164 | New | 0.04% | $0 M | Nov 10, 2026 |
| 54 | Brevan Howard Capital Management LP | 20,645 | -8,266 (-28.59%) | 0.04% | $0 M | Nov 16, 2026 |
| 55 | Axq Capital, LP | 18,890 | New | 0.03% | $0 M | Nov 12, 2026 |
| 56 | Canada Pension Plan Investment Board | 18,400 | New | 0.03% | $0 M | Nov 16, 2026 |
| 57 | MetLife Investment Management, LLC | 18,334 | -5,304 (-22.44%) | 0.03% | $0 M | Nov 16, 2026 |
| 58 | Captrust Financial Advisors | 18,329 | +4,272 (+30.39%) | 0.03% | $0 M | Nov 12, 2026 |
| 59 | MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 17,975 | -192 (-1.06%) | 0.03% | $0 M | Nov 16, 2026 |
| 60 | Vanguard Global Advisers, LLC | 17,714 | +2,146 (+13.78%) | 0.03% | $0 M | Nov 13, 2026 |
| 61 | Point72 Asset Management, L.P. | 17,075 | New | 0.03% | $0 M | Nov 16, 2026 |
| 62 | State of Wyoming | 14,940 | +3,199 (+27.25%) | 0.03% | $0 M | Oct 28, 2026 |
| 63 | Traynor Capital Management, Inc. | 14,920 | New | 0.03% | $0 M | Oct 29, 2026 |
| 64 | LPL Financial LLC | 14,677 | +2,128 (+16.96%) | 0.03% | $0 M | Nov 6, 2026 |
| 65 | Group One Trading LLC | 14,196 | New | 0.03% | $0 M | Nov 10, 2026 |
| 66 | Wells Fargo & Company/mn | 12,858 | -24,555 (-65.63%) | 0.02% | $0 M | Nov 16, 2026 |
| 67 | FMR LLC | 12,846 | +11,752 (+1074.22%) | 0.02% | $0 M | Nov 10, 2026 |
| 68 | Cetera Investment Advisers | 12,723 | +929 (+7.88%) | 0.02% | $0 M | Nov 13, 2026 |
| 69 | StoneX Group Inc. | 12,625 | New | 0.02% | $0 M | Nov 3, 2026 |
| 70 | Alliancebernstein L.P. | 12,000 | 0 (0.00%) | 0.02% | $0 M | Nov 16, 2026 |
| 71 | Mercer Global Advisors Inc /adv | 11,832 | New | 0.02% | $0 M | Nov 16, 2026 |
| 72 | Police & Firemen's Retirement System of New Jersey | 11,636 | 0 (0.00%) | 0.02% | $0 M | Nov 9, 2026 |
| 73 | Creative Planning | 10,715 | New | 0.02% | $0 M | Nov 2, 2026 |
| 74 | Manufacturers Life Insurance Company, The | 10,495 | -965 (-8.42%) | 0.02% | $0 M | Nov 13, 2026 |
| 75 | Inceptionr LLC | 10,390 | New | 0.02% | $0 M | Nov 16, 2026 |
| 76 | New York State Common Retirement Fund | 10,100 | 0 (0.00%) | 0.02% | $0 M | Nov 17, 2026 |
| 77 | Quantbot Technologies LP | 9,361 | New | 0.02% | $0 M | Nov 12, 2026 |
| 78 | Royal Bank Of Canada | 6,523 | +798 (+13.94%) | 0.01% | $0 M | Nov 16, 2026 |
| 79 | Arax Advisory Partners | 4,292 | +4,289 (+142966.67%) | 0.01% | $0 M | Nov 12, 2026 |
| 80 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 4,027 | New | 0.01% | $0 M | Nov 16, 2026 |
| 81 | Legal & General Group Plc | 3,837 | 0 (0.00%) | 0.01% | $0 M | Nov 16, 2026 |
| 82 | Ameritas Investment Partners, Inc. | 3,580 | 0 (0.00%) | 0.01% | $0 M | Nov 13, 2026 |
| 83 | Tower Research Capital LLC (TRC) | 3,259 | +2,333 (+251.94%) | 0.01% | $0 M | Nov 16, 2026 |
| 84 | Pfizer Inc | 2,171 | New | 0.00% | $0 M | Nov 12, 2026 |
| 85 | Osaic Holdings, Inc. | 2,120 | -72 (-3.28%) | 0.00% | $0 M | Nov 12, 2026 |
| 86 | Ameritas Advisory Services, LLC | 1,880 | 0 (0.00%) | 0.00% | $0 M | Nov 12, 2026 |
| 87 | Decker Retirement Planning Inc. | 1,800 | 0 (0.00%) | 0.00% | $0 M | Oct 19, 2026 |
| 88 | Tidemark, LLC | 1,583 | 0 (0.00%) | 0.00% | $0 M | Nov 9, 2026 |
| 89 | Caitong International Asset Management Co., Ltd | 1,388 | +1,332 (+2378.57%) | 0.00% | $0 M | Oct 29, 2026 |
| 90 | Sterling Capital Management LLC | 1,294 | +1,155 (+830.94%) | 0.00% | $0 M | Oct 22, 2026 |
| 91 | Parallel Advisors, LLC | 934 | New | 0.00% | $0 M | Nov 3, 2026 |
| 92 | Farther Finance Advisors, LLC | 854 | New | 0.00% | $0 M | Oct 8, 2026 |
| 93 | Allworth Financial LP | 842 | +646 (+329.59%) | 0.00% | $0 M | Nov 17, 2026 |
| 94 | BFC Planning, Inc. | 660 | 0 (0.00%) | 0.00% | $0 M | Nov 13, 2026 |
| 95 | Harbour Investments, Inc. | 605 | 0 (0.00%) | 0.00% | $0 M | Nov 9, 2026 |
| 96 | SBI Securities Co., Ltd. | 548 | +470 (+602.56%) | 0.00% | $0 M | Oct 22, 2026 |
| 97 | California State Teachers Retirement System | 543 | 0 (0.00%) | 0.00% | $0 M | Nov 13, 2026 |
| 98 | Rockefeller Capital Management L.P. | 500 | -60 (-10.71%) | 0.00% | $0 M | Nov 13, 2026 |
| 99 | Global Retirement Partners, LLC | 430 | +91 (+26.84%) | 0.00% | $0 M | Nov 10, 2026 |
| 100 | NFSG Corp | 395 | 0 (0.00%) | 0.00% | $0 M | Oct 15, 2026 |
Mutual funds holding Senseonics Holdings, Inc.#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc. | 1.18 M | $7 M | 1.4% | <0.01% | +2.0% | Jun 30, 2026 |
| 🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors | 972,810 | $6 M | 1.2% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc. | 559,672 | $3 M | 0.68% | <0.01% | +31% | Jun 30, 2026 |
| 🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC | 430,028 | $2 M | 0.52% | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 iShares Russell 2000 Growth ETFBlackRock Fund Advisors | 370,510 | $2 M | 0.45% | 0.01% | new | Jun 30, 2026 |
| 🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC | 184,805 | $1 M | 0.23% | <0.01% | −6.8% | May 31, 2026 |
| 🇺🇸 Schwab U.S. Small-Cap ETFCharles Schwab Investment Management, Inc. | 179,484 | $1 M | 0.22% | <0.01% | −1.6% | May 31, 2026 |
| 🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors | 132,509 | $1 M | 0.16% | 0.05% | new | Jun 30, 2026 |
| 🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC | 74,026 | $1 M | 0.09% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc. | 96,032 | $0 M | 0.12% | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC | 73,750 | $0 M | 0.09% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC | 57,316 | $0 M | 0.07% | <0.01% | +6.4% | May 31, 2026 |
| 🇺🇸 Ultra-Small Company Market FundBridgeway Capital Management, LLC | 62,100 | $0 M | 0.08% | 0.24% | +25% | Jun 30, 2026 |
| 🇺🇸 iShares Core S&P Total U.S. Stock Market ETFBlackRock Fund Advisors | 51,099 | $0 M | 0.06% | <0.01% | +2.2% | Jun 30, 2026 |
| 🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC | 52,133 | $0 M | 0.06% | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC | 42,291 | $0 M | 0.05% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 Schwab Total Stock Market Index FundCharles Schwab Investment Management, Inc. | 47,105 | $0 M | 0.06% | <0.01% | +199% | Jul 31, 2026 |
| 🇺🇸 Fidelity Small Cap Growth Index FundFidelity Management & Research Company LLC | 36,781 | $0 M | 0.04% | 0.01% | new | Jun 30, 2026 |
| 🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC | 25,810 | $0 M | 0.03% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation | 29,400 | $0 M | 0.04% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 Schwab U.S. Broad Market ETFCharles Schwab Investment Management, Inc. | 22,534 | $0 M | 0.03% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Fidelity ZERO Total Market Index FundFidelity Management & Research Company LLC | 27,775 | $0 M | 0.03% | <0.01% | +52% | Jul 31, 2026 |
| 🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc. | 22,888 | $0 M | 0.03% | <0.01% | +15% | Jun 30, 2026 |
| 🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc. | 21,648 | $0 M | 0.03% | <0.01% | +14% | Jun 30, 2026 |
| 🇺🇸 Small Cap Index FundNorthern Trust Investments, Inc. | 20,553 | $0 M | 0.03% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 T. Rowe Price Extended Equity Market Index FundT. Rowe Price Associates, Inc. | 18,900 | $0 M | 0.02% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Global X Russell 2000 ETFGlobal X Management Company LLC | 18,825 | $0 M | 0.02% | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 Fidelity ZERO Extended Market Index FundFidelity Management & Research Company LLC | 18,080 | $0 M | 0.02% | <0.01% | +43% | Jul 31, 2026 |
| 🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P. | 14,922 | $0 M | 0.02% | <0.01% | +47% | Jun 30, 2026 |
| 🇺🇸 MetLife Russell 2000 Index PortfolioBrighthouse Investment Advisers, LLC | 13,402 | $0 M | 0.02% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC | 11,211 | $0 M | 0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC | 8,933 | $0 M | 0.01% | 0.02% | new | Jun 30, 2026 |
| 🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC | 8,743 | $0 M | 0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 Small Cap Index TrustJohn Hancock Variable Trust Advisers LLC | 8,725 | $0 M | 0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS | 8,652 | $0 M | 0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 Dimensional U.S. Core Equity 2 ETFDimensional Fund Advisors LP | 9,459 | $0 M | 0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Fidelity Flex Small Cap Index FundFidelity Management & Research Company LLC | 7,730 | $0 M | <0.01% | <0.01% | +34% | Jul 31, 2026 |
| 🇺🇸 U.S. Small Cap PortfolioDimensional Fund Advisors LP | 7,458 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 iShares Russell Small/Mid-Cap Index FundBlackRock Advisors, LLC | 7,461 | $0 M | <0.01% | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 DWS Small Cap Index VIPDWS Investment Management Americas, Inc. | 6,211 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 EQ/AB Small Cap Growth PortfolioEquitable Investment Management Group, LLC | 6,000 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC | 6,000 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 T. Rowe Price Small-Cap Index FundT. Rowe Price Associates, Inc. | 5,949 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 EQ/Morgan Stanley Small Cap Growth PortfolioEquitable Investment Management Group, LLC | 5,917 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC | 5,269 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 Voya RussellTM Small Cap Index PortfolioVoya Investments, LLC | 4,855 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 Dimensional U.S. Equity Market ETFDimensional Fund Advisors LP | 5,370 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Victory Extended Market Index FundVictory Capital Management Inc. | 5,299 | $0 M | <0.01% | <0.01% | +24% | Jul 31, 2026 |
| 🇺🇸 State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc. | 4,500 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 SA Small Cap Index PortfolioSunAmerica Asset Management, LLC | 4,620 | $0 M | <0.01% | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 PD Small-Cap Growth Index PortfolioPacific Life Fund Advisors LLC | 3,600 | $0 M | <0.01% | 0.01% | new | Jun 30, 2026 |
| 🇺🇸 CVT Russell 2000 Small Cap Index PortfolioCalvert Research and Management | 3,580 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 Venerable Small Cap Index FundVenerable Investment Advisers, LLC | 3,146 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 U.S. Micro Cap PortfolioDimensional Fund Advisors LP | 3,513 | $0 M | <0.01% | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 Nationwide Small Cap Index FundNATIONWIDE FUND ADVISORS | 3,505 | $0 M | <0.01% | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 Voya VACS Index Series SC PortfolioVoya Investments, LLC | 2,978 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 VIP Extended Market Index PortfolioFidelity Management & Research Company LLC | 2,721 | $0 M | <0.01% | <0.01% | +11% | Jun 30, 2026 |
| 🇺🇸 SmallCap Growth Fund IPrincipal Global Investors, LLC | 3,017 | $0 M | <0.01% | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 Strategic Equity Allocation TrustJohn Hancock Variable Trust Advisers LLC | 1,881 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 EQ/Franklin Small Cap Value Managed Volatility PortfolioEquitable Investment Management Group, LLC | 1,329 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 State Street Total Return V.I.S. FundSSGA Funds Management, Inc. | 996 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 VIP Total Market Index PortfolioFidelity Management & Research Company LLC | 821 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Total Stock Market Index TrustJohn Hancock Variable Trust Advisers LLC | 808 | $0 M | <0.01% | <0.01% | +2.0% | Jun 30, 2026 |
| 🇺🇸 Dimensional US Core Equity Market ETFDimensional Fund Advisors LP | 434 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 State Street Balanced Index FundSSGA Funds Management, Inc. | 249 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Knights of Columbus U.S. ALL CAP INDEX FUNDKnights of Columbus Asset Advisors LLC | 212 | $0 M | <0.01% | <0.01% | +7.1% | Jul 31, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 66 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Insider trading at Senseonics Holdings, Inc.#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Brian B. HansenChief Commercial Officer, Director | Shares withheld for tax | -7,850 | $10.58 | $83 K | 119,087 | Form 4 |
| filed | Kenneth L. HortonGC & Corp. Development Advisor | Shares withheld for tax | -16,865 | $10.58 | $178 K | 268,647 | Form 4 |
| filed | Timothy T. GoodnowPresident and CEO, Director | Shares withheld for tax | -61,198 | $10.58 | $647 K | 1.08 M | Form 4 |
| filed | Mukul JainChief Operating Officer | Shares withheld for tax | -30,687 | $10.58 | $325 K | 470,176 | Form 4 |
| filed | Francine KaufmanChief Medical Officer, Director | Shares withheld for tax | -10,068 | $10.58 | $107 K | 166,989 | Form 4 |
| filed | Frederick T. SullivanChief Financial Officer | Shares withheld for tax | -14,605 | $10.58 | $155 K | 211,872 | Form 4 |
| filed | Douglas A. RoederDirector | Buy | +17,041 | $10.32 | $176 K | 189,712 | Form 4 |
| filed | Douglas A. RoederDirector | Grant or award | +1,480 | $9.960 | $15 K | 172,671 | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals
Markets and events: Senseonics Holdings, Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
Stock splits: 1-for-20 reverse split ; 12-for-1 split in the period to
Fails to deliver
- : 1,511 shares at $9.24
- : 619 shares at $9.02
- : 239 shares at $9.88
- : 2,312 shares at $9.78
- : 505 shares at $9.58
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
Senseonics Holdings, Inc. scorecard#
Passes 9 of the 23 checks that could be worked out: strongest in growth (5 of 6), weakest in valuation (0 of 5). Fiscal year 2025; market cap of Oct 13, 2026.
Valuation0 of 5
- ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
- ✗Price to book below its peers' median8.3×Price to book 8.3× against Healthcare's median of 3.1×.
- ✗Price to sales below its peers' median8.4×Price to sales 8.4× against Healthcare's median of 3.8×.
- ✗Free cash flow yield above 5%-11.9%Free cash flow is -11.9% of the market value.
- ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 5.15% (2026-11-13).
- –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
Growth5 of 6
- ✓Revenue grew in the newest year56.9%Revenue up 56.9% in fiscal 2025.
- ✓Revenue up more than 5% a year over three years29.1%29.1% a year over the three years to fiscal 2025.
- ✓Faster growth over three years than its peers' median29.1%29.1% a year against Healthcare's median of 8.5% (549 companies).
- ✗Earnings per share grew in the newest year-1.66 vs -2.50Diluted EPS -1.66 in fiscal 2025 against -2.50 the year before (report's currency).
- ✓Net income higher than five years earlier-$69 M-$69 M in fiscal 2025 against -$175 M in 2020.
- ✓Revenue rose in at least four of the last five years5 of 5Revenue rose in 5 of the five years to fiscal 2025.
Profitability1 of 5
- ✗Profitable in the newest year-$69 MNet income -$69 M in fiscal 2025.
- ✗Profitable in each of the last five years1 of 5Profitable in 1 of the five years to fiscal 2025.
- ✗Operating margin above its peers' median-193.8%-193.8% against Healthcare's median of -7.7% (674 companies).
- ✗Return on equity above 15%-310.7%-310.7% in fiscal 2025.
- –Return on invested capital above 10%No return on invested capital on file.
- ✓Operating margin wider than three years earlier-193.8%-193.8% in fiscal 2025 against -418.7% in 2022.
Financial health3 of 6
- ✓Short-term assets cover short-term liabilities4.8×Current ratio 4.83 at the end of fiscal 2025.
- ✓Debt below equity0.6×Debt to equity 0.58 at the end of fiscal 2025.
- ✓Net debt below three years of EBITDANet cashMore cash than debt: net cash of $5 M at the end of fiscal 2025.
- ✗Operating income covers interest five times-13.8×Operating income -13.8 times interest in fiscal 2025.
- ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2025.
- ✗Altman Z-score outside the distress zone-7.24Z-score -7.24 (distress zone) for fiscal 2025.
Shareholder returns0 of 1
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- ✗Share count up no more than 2% in a year32.5%Diluted shares up 32.5% in fiscal 2025.
- –Dividends and buybacks above 3% of the market valueDividends and buybacks are not on file.
- –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.
Worked out from the statements as filed (sec), the medians of Healthcare, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Financial analysis, 2025#
Worked out from Senseonics Holdings, Inc.'s statements, beside the median of Healthcare.
| Ratio | Trend | 2025 | Median of peers |
|---|---|---|---|
| Operating margin | -193.8% | -7.7% | |
| Net margin | -196.0% | -8.1% | |
| Return on equity | -310.7% | -36.9% | |
| Revenue growth, 3 years a year | 29.1% | 8.5% | |
| Revenue growth | 56.9% | 10.2% | |
| Debt to equity | 0.58× | 0.45× |
6of 9on the Piotroski tests of financial strength
- Net loss of $69 million, the 3th loss-making year in a row.
- Free cash flow was negative: -$60 million.
- The share count rose 32.5% in the year.
- Operating income covers the interest bill only -13.8 times.
Senseonics Holdings, Inc.: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2025to Dec 31, 2025 | FY 2024to Dec 31, 2024 | FY 2023to Dec 31, 2023 | FY 2022to Dec 31, 2022 | FY 2021to Dec 31, 2021 | FY 2020to Dec 31, 2020 | FY 2019to Dec 31, 2019 | FY 2018to Dec 31, 2018 | FY 2017to Dec 31, 2017 | FY 2016to Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||
| Revenue | 35+56.9%100% | 22+0.4%100% | 22+36.6%100% | 16+19.8%100% | 14+176%100% | 4.9−76.8%100% | 21+12.6%100% | 19+197%100% | 6.4+1820%100% | 0.3—100% | |
| Cost of revenue | 19−11.1%55.3% | 22+13.7%97.6% | 19+41.3%86.2% | 14−5.7%83.4% | 14−35.1%106% | 22−45.2%451% | 41+50.6%191% | 27+177%143% | 9.8+1378%153% | 0.7—199% | |
| Gross profit | 16+2857%44.7% | 0.5−82.8%2.4% | 3.1+13.4%13.8% | 2.7—16.6% | −0.8—−5.9% | −17—−351% | −19—−91.3% | −8.1—−43.1% | −3.4—−53.1% | −0.3—−98.8% | |
| Research and development | 32−23.2%89.6% | 41−15.6%183% | 49+22.7%218% | 40+45.9%242% | 27+33.3%199% | 20−46.9%412% | 38+20.6%180% | 32+3.7%168% | 31+16.7%482% | 26—7936% | |
| Selling, general and administrative | 53+53.4%149% | 34+14.3%152% | 30−5.3%134% | 32+8.5%193% | 29−29.5%213% | 41—836% | — | — | — | — | |
| Selling and marketing | — | — | — | — | 5.5−73.3%40.1% | 21−58.5%415% | 50+78.7%233% | 28+304%147% | 6.9+151%108% | 2.7—824% | |
| General and administrative | — | — | — | — | 22+3.5%157% | 21−10.5%420% | 23+17.1%109% | 20+29.4%105% | 15+17.8%241% | 13—3922% | |
| Operating income | −68—−194% | −75—−333% | −76—−338% | −69—−419% | −57—−418% | −79—−1599% | −131—−613% | −88—−463% | −56—−884% | −42—−12781% | |
| Interest and finance income | 4.2−6.8%11.9% | 4.5−16.0%20.0% | 5.4+194%23.9% | 1.8+651%11.1% | 0.2+38.9%1.8% | 0.2−90.9%3.5% | 1.9−3.4%9.1% | 2.0+1382%10.6% | 0.1+68.8%2.1% | 0.1—24.1% | |
| Interest expense and finance costs | 5.0−41.3%14.0% | 8.4−24.1%37.5% | 11−40.6%49.6% | 19+11.9%114% | 17+3.4%122% | 16r37+37.0%327% | 12r12+42.5%55.4% | 8.3+167%43.8% | 3.1+93.4%48.6% | 1.6—483% | |
| Other non-operating income (expense) | −0.8—−2.2% | −3.8−125%−16.8% | 15−92.8%67.9% | 211—1286% | −245—−1794% | −96−735%−1941% | 15—70.9% | −6.4—−33.8% | −2.8r0.2—−43.7% | −1.5r0.0—−451% | |
| Income before tax | −69—−196% | −79—−350% | — | — | — | — | — | — | — | — | |
| Income tax | 0—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | — | 0—0.0% | 0—0.0% | 0—0.0% | |
| Net income including minority interests | −69—−196% | −79—−350% | −60−142%−270% | 142—867% | −302—−2212% | −175—−3539% | −116—−542% | −94—−497% | −59—−927% | −44—−13232% | |
| Net income attributable to shareholders | −69—−196% | −79—−350% | −60−142%−270% | 142—867% | −302—−2212% | −175—−3539% | −116—−542% | −94—−497% | −59—−927% | −44—−13232% | |
| Earnings per share, basic | -1.66—— | -2.50r-0.12—— | -0.11−137%— | 0.30—— | -0.72—— | -0.77—— | -0.61—— | -0.60—— | -0.51—— | -0.49—— | |
| Earnings per share, diluted | -1.66—— | -2.50r-0.12—— | -0.11—— | -0.11—— | -0.72—— | -0.77—— | -0.61—— | -0.60—— | -0.51—— | -0.49—— | |
| Shares, weighted average (basic) | 42+32.5%— | 31r630−94.5%— | 568+21.4%— | 468+10.8%— | 422+85.3%— | 228+20.7%— | 189—— | — | — | — | |
| Shares, weighted average (diluted) | 42+32.5%— | 31r630−94.5%— | 568−8.1%— | 618+46.4%— | 422+85.3%— | 228+20.7%— | 189+19.9%— | 157+35.7%— | 116+30.0%— | 89—— | |
| Balance sheet | |||||||||||
| Cash and cash equivalents | 40−46.1%31.9% | 75−1.5%74.3% | 76+112%54.8% | 36+7.0%20.1% | 33+85.8%16.8% | 18−81.2%50.1% | 96−29.9%72.2% | 137+747%85.5% | 16+23.8%35.2% | 13—58.6% | |
| Short-term investments | 54—42.6% | 0−100%0.0% | 34−68.8%24.4% | 108+12.2%60.9% | 96—48.5% | — | — | 0−100%0.0% | 20+178%44.2% | 7.3—32.7% | |
| Receivables | 12+92.8%9.6% | 6.3—6.3% | — | — | — | — | — | — | — | — | |
| Inventory | 6.7+51.6%5.3% | 4.4−49.6%4.4% | 8.8+20.1%6.3% | 7.3+15.7%4.1% | 6.3+19.6%3.2% | 5.3−68.8%14.7% | 17+65.5%12.7% | 10+242%6.4% | 3.0+527%6.5% | 0.5—2.1% | |
| Other current assets | 4.4−25.0%3.5% | 5.8−19.9%5.8% | 7.3−2.2%5.3% | 7.4+19.5%4.2% | 6.2+64.8%3.1% | 3.8−16.4%10.5% | 4.5+13.2%3.4% | 4.0+8202%2.5% | 0.0−23.8%0.1% | 0.1r0.4—0.3% | |
| Current assets | 118+28.5%93.1% | 91−29.7%91.0% | 130−19.3%94.1% | 161+11.6%90.7% | 144+377%72.6% | 30−76.3%84.2% | 128−19.2%96.2% | 158+252%98.8% | 45+110%97.8% | 21—96.2% | |
| Property, plant and equipment | — | — | 1.2+6.5%0.9% | 1.1−15.0%0.6% | 1.3−16.0%0.7% | 1.6−22.2%4.3% | 2.0+14.3%1.5% | 1.8+105%1.1% | 0.9+16.1%1.9% | 0.7—3.3% | |
| Right-of-use (leased) assets | 4.5−7.8%3.5% | 4.8−6.6%4.8% | 5.2+70.8%3.7% | 3.0+269%1.7% | 0.8−61.4%0.4% | 2.1−24.6%5.9% | 2.8—2.1% | — | — | — | |
| Other intangible assets | 0.6—0.5% | — | — | — | — | — | — | — | — | — | |
| Long-term investments | — | — | — | 12−76.4%6.9% | 52—26.1% | — | — | — | — | — | |
| Total assets | 126+25.7%100% | 100−27.3%100% | 138−22.2%100% | 178−10.7%100% | 199+454%100% | 36−73.0%100% | 133−17.0%100% | 160+248%100% | 46+106%100% | 22—100% | |
| Accounts payable | 4.1+26.6%3.2% | 3.2−29.8%3.2% | 4.6+990%3.3% | 0.4−65.2%0.2% | 1.2−31.7%0.6% | 1.8−58.9%4.9% | 4.3−2.8%3.2% | 4.4−42.9%2.8% | 7.7+151%16.8% | 3.1—13.8% | |
| Current liabilities | 24−37.3%19.3% | 39+125%38.7% | 17−45.2%12.5% | 31+71.1%17.7% | 18+10.6%9.2% | 17−86.9%46.3% | 127+339%95.4% | 29+24.8%18.1% | 23+99.1%50.4% | 12—52.2% | |
| Lease liabilities (non-current) | 5.3−8.6%4.2% | 5.8−6.9%5.8% | 6.2+131%4.5% | 2.7r2.7+364%1.5% | 0.6r0.6−61.0%0.3% | 1.5−34.9%4.1% | 2.3—1.7% | — | — | — | |
| Total liabilities | 65−17.8%51.7% | 79+22.5%79.0% | 65−54.6%46.9% | 143−62.9%80.3% | 384+117%193% | 177+25.3%493% | 141+59.4%107% | 89+129%55.5% | 39+42.5%84.2% | 27—122% | |
| Retained earnings | −1,017—−805% | −948—−944% | −869—−629% | −809—−455% | −951—−478% | −649—−1806% | −473—−356% | −358—−224% | −264—−574% | −205—−919% | |
| Shareholders' equity | 61—48.3% | −17−146%−16.5% | 36—25.9% | −2.6—−1.4% | −186—−93.3% | −144—−401% | −8.6−112%−6.5% | 71+881%44.5% | 7.3—15.8% | −4.9—−21.9% | |
| Total liabilities and equity | 126+25.7%100% | 100−27.3%100% | 138−22.2%100% | 178−10.7%100% | 199+454%100% | 36−73.0%100% | 133−17.0%100% | 160+248%100% | 46+106%100% | 22—100% | |
| Shares outstanding | 41+38.6%— | 30r595−94.4%— | 530+10.6%— | 480+7.2%— | 447+68.4%— | 266+30.5%— | 203+15.0%— | 177+29.2%— | 137+46.3%— | 94—— | |
| Cash-flow statement | |||||||||||
| Depreciation and amortization | 1.5+2.5%4.3% | 1.5+15.5%6.6% | 1.3+29.6%5.7% | 1.0−20.5%6.0% | 1.2+8.6%9.1% | 1.1+14.0%23.1% | 1.0+271%4.7% | 0.3+18.9%1.4% | 0.2+46.5%3.6% | 0.2—46.7% | |
| Share-based compensation | 10+10.1%28.8% | 9.2+6.4%41.1% | 8.7+0.6%38.7% | 8.6−4.6%52.6% | 9.0+23.4%66.0% | 7.3−9.2%148% | 8.1+25.6%37.8% | 6.4+60.6%33.9% | 4.0+64.9%62.7% | 2.4—729% | |
| Cash from operating activities | −59—−168% | −60—−269% | −70—−313% | −66—−405% | −56—−410% | −67—−1362% | −136—−639% | −91—−480% | −56—−875% | −38—−11451% | |
| Capital expenditure | −1.1—−3.2% | −2.2—−10.0% | −0.4—−1.6% | −0.3—−1.9% | −0.2—−1.5% | −0.2—−3.7% | −1.0—−4.9% | −1.0—−5.2% | −0.3—−5.4% | −0.5—−144% | |
| Cash from investing activities | −53−263%−152% | 33−63.4%146% | 90+234%401% | 27—164% | −149—−1088% | −0.2—−3.7% | −1.0−105%−4.9% | 19—103% | −13—−208% | −7.8—−2340% | |
| Debt issued | — | — | — | — | — | 56−55.9%1131% | 127+140%596% | 53—280% | — | — | |
| Shares issued | — | — | — | — | — | — | 29−80.8%135% | 150+121%790% | 68+46.3%1060% | 46—13911% | |
| Cash from financing activities | 78+191%222% | 27+31.7%119% | 20−51.2%91.0% | 42−81.0%255% | 220—1609% | −10−111%−205% | 96−49.9%452% | 192+166%1015% | 72+31.3%1131% | 55—16534% | |
| Change in cash | −34—−97.5% | −0.8−102%−3.5% | 40+1612%178% | 2.3−84.7%14.2% | 15—112% | −78—−1571% | −41−134%−192% | 121+3788%638% | 3.1−65.9%48.7% | 9.1—2743% | |
| Report | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | |
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the same quarter a year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | Last 12 months4 quarters to Sep 30, 2026 | Q3 FY2026to Sep 30, 2026 | Q2 FY2026to Jun 30, 2026 | Q1 FY2026to Mar 31, 2026 | Q4 FY2025to Dec 31, 2025 | Q3 FY2025to Sep 30, 2025 | Q2 FY2025to Jun 30, 2025 | Q1 FY2025to Mar 31, 2025 | Q4 FY2024to Dec 31, 2024 | Q3 FY2024to Sep 30, 2024 | Q2 FY2024to Jun 30, 2024 | Q1 FY2024to Mar 31, 2024 | Q4 FY2023to Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||||||
| Revenue | 60+105%100% | 20+142%100% | 14+118%100% | 12+87.2%100% | 14*+71.8%100% | 8.1+89.9%100% | 6.6+36.7%100% | 6.3+24.0%100% | 8.3*+3.3%100% | 4.3—100% | 4.9—100% | 5.0—100% | 8.0*—100% | |
| Cost of revenue | 25+43.6%41.3% | 7.5+61.9%38.3% | 5.9+67.9%40.9% | 4.8+0.4%40.7% | 6.6*+51.6%46.2% | 4.6−44.3%57.2% | 3.5−22.8%53.1% | 4.8+0.8%75.9% | 4.3*−37.4%52.4% | 8.3—195% | 4.6—93.9% | 4.7—93.4% | 6.9*—86.4% | |
| Gross profit | 35+193%58.7% | 12+248%61.7% | 8.6+174%59.1% | 6.9+361%59.3% | 7.7*+94.1%53.8% | 3.5—42.8% | 3.1+947%46.9% | 1.5+349%24.1% | 4.0*+263%47.6% | −4.1—−95.0% | 0.3—6.1% | 0.3—6.6% | 1.1*—13.6% | |
| Research and development | 41+26.8%67.9% | 12+50.4%59.6% | 12+50.9%80.4% | 8.6+18.0%73.5% | 8.8*−5.8%61.9% | 7.8−26.4%95.8% | 7.7−28.6%116% | 7.3−30.1%117% | 9.4*−12.9%113% | 11—247% | 11—222% | 10—207% | 11*—134% | |
| Selling, general and administrative | 115+177%192% | 32+111%165% | 33+238%227% | 30+292%258% | 20*+123%139% | 15+85.6%189% | 9.7+8.2%146% | 7.7−5.4%123% | 8.9*+20.7%107% | 8.3—194% | 9.0—185% | 8.1—161% | 7.3*—91.5% | |
| Operating income | −121—−201% | −32—−163% | −36—−248% | −32—−272% | −21*—−147% | −20—−242% | −14—−215% | −13—−216% | −14*—−172% | −23—−536% | −19—−401% | −18—−361% | −17*—−212% | |
| Interest and finance income | 4.3+12.1%7.1% | 1.2−5.1%6.0% | 1.0+6.1%7.1% | 0.7+9.9%6.3% | 1.3*+43.1%9.2% | 1.2+22.4%15.3% | 1.0−18.2%14.6% | 0.7−51.2%10.8% | 0.9*−38.1%11.1% | 1.0—23.7% | 1.2—24.5% | 1.4—27.4% | 1.5*—18.5% | |
| Interest expense and finance costs | 5.8−1.8%9.7% | 1.8+54.8%9.3% | 1.6+39.7%11.0% | 1.2−16.6%10.2% | 1.2*−44.4%8.5% | 1.2−45.1%14.5% | 1.1−45.1%17.2% | 1.4−30.2%22.8% | 2.2*+26.1%26.2% | 2.1—50.0% | 2.1—42.9% | 2.0—40.6% | 1.7*—21.4% | |
| Other non-operating income (expense) | −1.9—−3.2% | −0.8−1256%−4.2% | −0.7—−5.0% | −0.5—−4.2% | 0.1*—0.7% | 0.1—0.9% | −0.2—−2.7% | −0.8—−12.3% | −1.2*—−14.5% | −1.1—−26.5% | −0.8—−16.3% | −0.6—−12.8% | −0.2*—−2.3% | |
| Income tax | 0—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | 0*—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | 0*—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | 0*—0.0% | |
| Net income including minority interests | −123—−204% | −33*—−167% | −37*—−253% | −32—−276% | −21*—−146% | −20*—−241% | −15*—−218% | −14—−228% | −15*—−187% | −24*—−562% | −20*—−417% | −19—−374% | −17*—−214% | |
| Net income attributable to shareholders | −123—−204% | −33—−167% | −37—−253% | −32—−276% | −21*—−146% | −20—−241% | −15—−218% | −14—−228% | −15*—−187% | −24—−562% | −20—−417% | −19—−374% | −17*—−214% | |
| Earnings per share, basic | — | -0.50—— | -0.63—— | -0.71—— | — | -0.43—— | -0.36r-0.02—— | -0.40r-0.02—— | — | -0.77r-0.04—— | -0.03—— | -0.03—— | — | |
| Earnings per share, diluted | — | -0.50—— | -0.63—— | -0.71—— | — | -0.43—— | -0.36r-0.02—— | -0.40r-0.02—— | — | -0.77r-0.04—— | -0.03—— | -0.03—— | — | |
| Shares, weighted average (basic) | 66+46.2%— | 66+46.2%— | 58+42.2%— | 46+27.5%— | — | 45+44.8%— | 41r813−93.4%— | 36r719−94.2%— | — | 31r621—— | 617—— | 615—— | — | |
| Shares, weighted average (diluted) | 66+46.2%— | 66+46.2%— | 58+42.2%— | 46+27.5%— | — | 45+44.8%— | 41r813−93.4%— | 36r719−94.2%— | — | 31r621—— | 617—— | 615—— | — | |
| Balance sheet | ||||||||||||||
| Cash and cash equivalents | 48—29.4% | 48+38.6%29.4% | 45+42.0%25.3% | 30−24.7%28.8% | 40−46.1%31.9% | 34+27.1%24.6% | 32−9.6%21.0% | 39−56.6%45.1% | 75−1.5%74.3% | 27—28.1% | 35—31.2% | 91—71.6% | 76—54.8% | |
| Short-term investments | 79—48.3% | 79+2.7%48.3% | 98+3.2%55.4% | 35+39.2%33.7% | 54—42.6% | 76+61.5%54.7% | 95+90.6%63.1% | 25+205%28.6% | 0−100%0.0% | 47—49.2% | 50—44.6% | 8.2—6.5% | 34—24.4% | |
| Receivables | 13—8.1% | 13+82.1%8.1% | 10+99.1%5.8% | 15+225%14.3% | 12+92.8%9.6% | 7.2—5.1% | 5.2—3.4% | 4.5—5.2% | 6.3—6.3% | — | — | — | — | |
| Inventory | 8.4—5.2% | 8.4+33.5%5.2% | 8.5+79.4%4.8% | 8.3+84.2%8.1% | 6.7+51.6%5.3% | 6.3+97.2%4.5% | 4.7−34.7%3.1% | 4.5−43.4%5.2% | 4.4−49.6%4.4% | 3.2—3.3% | 7.2—6.5% | 8.0—6.3% | 8.8—6.3% | |
| Other current assets | 4.7—2.9% | 4.7−26.9%2.9% | 4.8−4.7%2.7% | 4.6−3.3%4.5% | 4.4−25.0%3.5% | 6.5+14.5%4.6% | 5.0−23.3%3.3% | 4.8−35.6%5.5% | 5.8−19.9%5.8% | 5.7—5.9% | 6.5—5.8% | 7.4—5.9% | 7.3—5.3% | |
| Current assets | 153—94.1% | 153+16.5%94.1% | 166+17.6%94.1% | 92+17.7%89.7% | 118+28.5%93.1% | 131+49.7%93.8% | 142+37.4%94.2% | 78−33.7%89.9% | 91−29.7%91.0% | 88—91.0% | 103—92.3% | 118—93.4% | 130—94.1% | |
| Property, plant and equipment | — | — | — | — | — | — | — | — | — | 3.4—3.6% | 3.3—3.0% | 1.4—1.1% | 1.2—0.9% | |
| Right-of-use (leased) assets | 5.1—3.1% | 5.1+12.0%3.1% | 5.8+25.5%3.3% | 6.1+27.5%5.9% | 4.5−7.8%3.5% | 4.6−7.5%3.3% | 4.7−7.2%3.1% | 4.7−6.9%5.4% | 4.8−6.6%4.8% | 4.9—5.1% | 5.0—4.5% | 5.1—4.0% | 5.2—3.7% | |
| Other intangible assets | — | — | — | — | 0.6—0.5% | — | — | — | — | — | — | — | — | |
| Total assets | 163—100% | 163+16.1%100% | 177+17.7%100% | 103+17.9%100% | 126+25.7%100% | 140+45.3%100% | 150+34.7%100% | 87−31.1%100% | 100−27.3%100% | 96—100% | 112—100% | 127—100% | 138—100% | |
| Accounts payable | 2.5—1.5% | 2.5−57.8%1.5% | 4.8+113%2.7% | 3.2+58.8%3.1% | 4.1+26.6%3.2% | 5.9+182%4.2% | 2.3+70.5%1.5% | 2.0+197%2.3% | 3.2−29.8%3.2% | 2.1—2.2% | 1.3—1.2% | 0.7—0.5% | 4.6—3.3% | |
| Current liabilities | 26—15.9% | 26+22.5%15.9% | 25+67.0%14.0% | 26+131%25.6% | 24−37.3%19.3% | 21−40.7%15.1% | 15−55.4%9.8% | 11−61.8%13.1% | 39+125%38.7% | 36—36.9% | 33—29.7% | 30—23.6% | 17—12.5% | |
| Lease liabilities (non-current) | 4.9—3.0% | 4.9−10.1%3.0% | 6.0+8.8%3.4% | 6.3+10.9%6.1% | 5.3−8.6%4.2% | 5.4−8.1%3.9% | 5.5−7.7%3.7% | 5.7−7.3%6.5% | 5.8−6.9%5.8% | 5.9—6.1% | 6.0—5.4% | 6.1—4.8% | 6.2—4.5% | |
| Total liabilities | 85—52.2% | 85+37.4%52.2% | 87+55.7%48.9% | 69+31.7%66.6% | 65−17.8%51.7% | 62−18.6%44.1% | 56−24.2%37.0% | 52−25.6%59.6% | 79+22.5%79.0% | 76—78.7% | 73—65.7% | 70—55.2% | 65—46.9% | |
| Retained earnings | −1,119—−688% | −1,119—−688% | −1,086—−614% | −1,049—−1020% | −1,017—−805% | −996—−712% | −977—−650% | −962—−1103% | −948—−944% | −932—−968% | −908—−814% | −888—−702% | −869—−629% | |
| Shareholders' equity | 78—47.8% | 78−0.7%47.8% | 90−4.7%51.1% | 34−2.4%33.4% | 61—48.3% | 78—55.9% | 95+16288%63.0% | 35+85.6%40.4% | −17−146%−16.5% | −17—−17.8% | 0.6—0.5% | 19—15.0% | 36—25.9% | |
| Total liabilities and equity | 163—100% | 163+16.1%100% | 177+17.7%100% | 103+17.9%100% | 126+25.7%100% | 140+45.3%100% | 150+34.7%100% | 87−31.1%100% | 100−27.3%100% | 96—100% | 112—100% | 127—100% | 138—100% | |
| Shares outstanding | 55—— | 55+34.2%— | 53−93.5%— | 42−93.6%— | 41+38.6%— | 41−92.5%— | 815+52.2%— | 654+23.2%— | 30r595−94.4%— | 546—— | 535—— | 531—— | 530—— | |
| Cash-flow statement | ||||||||||||||
| Depreciation and amortization | 2.0+3.0%3.3% | 0.5*+27.1%2.4% | 0.5*+48.1%3.8% | 0.5+41.9%4.7% | 0.4*−50.1%2.7% | 0.4*+91.8%4.6% | 0.4*+7.6%5.6% | 0.4+127%6.1% | 0.8*+20.4%9.2% | 0.2*—4.6% | 0.3*—7.1% | 0.2—3.3% | 0.6*—7.9% | |
| Share-based compensation | 12+25.4%20.0% | 3.6*+27.4%18.2% | 3.6*+23.4%24.6% | 2.3+23.7%19.4% | 2.6*+27.1%18.4% | 2.8*+14.9%34.5% | 2.9*−1.1%43.5% | 1.8+2.2%29.4% | 2.1*+6.6%24.9% | 2.4*—57.1% | 2.9*—60.1% | 1.8—35.7% | 1.9*—24.1% | |
| Cash from operating activities | −113—−188% | −33*—−168% | −30*—−208% | −32—−273% | −18*—−126% | −16*—−195% | −9.3*—−139% | −16—−257% | −14*—−172% | −15*—−348% | −11*—−229% | −20—−401% | −15*—−188% | |
| Capital expenditure | −1.0—−1.6% | −0.2*—−1.2% | −0.2*—−1.5% | −0.1—−0.9% | −0.4*—−2.8% | −0.2*—−2.0% | −0.1*—−1.9% | −0.4—−6.9% | −0.0*—−0.4% | — | −2.1*—−43.0% | −0.3—−6.3% | −0.2*—−2.1% | |
| Cash from investing activities | −3.2—−5.4% | 20*+3.3%99.8% | −63*—−438% | 18—154% | 23*−52.5%159% | 19*+469%233% | −70*—−1047% | −25−200%−405% | 48*+31.7%574% | 3.3*—77.9% | −44*—−895% | 25—503% | 36*—451% | |
| Shares issued | — | — | 50*−30.8%345% | 3.5−86.8%29.8% | — | — | 72*—1087% | 26—423% | — | — | — | — | — | |
| Cash from financing activities | 130+42.2%216% | 16*—84.0% | 109*+52.8%750% | 3.4−44.3%29.1% | 1.1*−92.2%7.7% | −0.1*−104%−1.7% | 71*—1069% | 6.1−39.0%97.8% | 14*—170% | 3.7*—87.8% | −1.0*—−20.9% | 10—199% | −1.2*—−14.7% | |
| Change in cash | 13+80.9%22.2% | 3.0*+2.2%15.4% | 15*—105% | −11—−90.7% | 5.8*−87.8%40.5% | 2.9*—36.3% | −7.8*—−117% | −35−333%−564% | 47*+138%572% | −7.8*—−182% | −56*—−1145% | 15—300% | 20*—248% | |
| Report | Worked out | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | |
* Worked out from reported figures: a quarter the company states only within a year-to-date figure (cash flows are reported that way), or the fourth quarter as the fiscal year minus the first nine months.
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
What Senseonics Holdings, Inc. sells: revenue by product line, fiscal 2025#
As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.
Business segments
- Single reportable segment$35 M100%+57%
Countries and regions
- 🇺🇸 USA$28 M79%+83%
- Outside of the United States(total)$7 M21%+2.2%
Source: SEC annual report (XBRL data) · as of Dec 31, 2025
Executive pay at Senseonics Holdings, Inc.#
From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.
| Fiscal year | CEO total pay | Actually paid | Other executives, average | $100 invested |
|---|---|---|---|---|
| 2025Timothy T. Goodnow | $3.3 M | $1.7 M | $1.7 M | $27 |
| 2024Timothy T. Goodnow | $3.3 M | $3.1 M | $1.6 M | $20 |
| 2023Timothy T. Goodnow | $3.6 M | $2.0 M | $1.5 M | $21 |
Source: SEC proxy statement (Form DEF 14A) · as of Dec 31, 2025
Events at Senseonics Holdings, Inc.#
What the company reported to the SEC within four business days (Form 8-K), newest first.
No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.
Directors and officers 2 · Material agreement 7 · New debt 2 · Unregistered share sale 1 · Shareholder rights changed 1 · Bylaws or fiscal year changed 2 · Shareholder vote 3 · Results announced 12
| Filed | What happened | Filing |
|---|---|---|
| Results announced | 8-K | |
| Results announced | 8-K | |
| Bylaws or fiscal year changedShareholder vote | 8-K | |
| Results announced | 8-K | |
| Material agreementNew debt | 8-K | |
| Material agreementResults announced | 8-K | |
| Material agreement | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Directors and officersMaterial agreement | 8-K | |
| Results announced | 8-K | |
| Shareholder rights changedBylaws or fiscal year changed | 8-K | |
| Results announced | 8-K | |
| Shareholder vote | 8-K | |
| Material agreementNew debt | 8-K | |
| Results announced | 8-K | |
| Shareholder vote | 8-K | |
| Material agreement | 8-K | |
| Material agreementUnregistered share sale | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Results announced | 8-K |
Source: SEC EDGAR, Form 8-K item numbers · as of Nov 9, 2026
Acquisitions and funding#
Private share sales · funding history
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| May 2025 | $20 M | Private placement after listing | $10 to $50 million | 1 | equity | SEC |
| Oct 2024 | $16 M | Private placement after listing | $10 to $50 million | 1 | equity, options | SEC |
| Aug 2020 | $3 M | Private placement after listing | $2 to $10 million | 2 | equity | SEC |
Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.
Discuss Senseonics Holdings, Inc.#
2 automatic updates and 0 member comments. Sign in to comment and react.
- Results announced on 9 November 2026automatic update · Nov 9, 2026
Senseonics Holdings, Inc. announced results on 9 November 2026 (SEC Form 8-K, item 2.02). For the quarter ended 30 September 2026: revenue of $20 million (up 141% from a year earlier) and a net loss of $33 million.
- Mutual funds: 66 funds hold $29 millionautomatic update · Jul 31, 2026
66 mutual funds in 1 country hold shares of Senseonics Holdings, Inc. worth $29 million, about 6.1% of the company (funds' newest reports, up to 31 July 2026). Since their previous reports 54 funds added shares and 5 sold; on balance they bought $14 million. Share splits are not counted as trading.
How Senseonics Holdings, Inc. compares in Healthcare
- Market cap$506 M · higher than 45% of 2,013
- Revenue$35 M · higher than 30% of 1,795
- Net margin-204.2% · higher than 11% of 1,485
- Revenue growth56.9% · higher than 84% of 1,003
- Price / sales8.4× · lower than 26% of 1,071
- Price / book8.3× · lower than 17% of 1,245
- FCF yield-11.9% · higher than 39% of 835
Peer comparison · Healthcare
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Senseonics Holdings, Inc.🇺🇸 | $506 M | — | -204.2% | +56.9% |
| Eli Lilly and Company🇺🇸 | $1.20 T | 43.4× | 31.9% | +44.7% |
| Johnson & Johnson🇺🇸 | $652.5 B | 40.5× | 16.2% | +6.0% |
| AbbVie Inc.🇺🇸 | $514.0 B | 49.7× | 15.7% | +8.6% |
| Roche Holding AG🇨🇭 | $370.3 B | 29.1× | 19.0% | — |
| UnitedHealth Group Incorporated🇺🇸 | $367.7 B | 23.1× | 3.5% | +11.8% |
| Merck & Co., Inc.🇺🇸 | $359.8 B | 146.7× | 3.6% | +1.3% |
| Novartis AG🇨🇭 | $286.8 B | 20.5× | 24.7% | — |
| Thermo Fisher Scientific Inc.🇺🇸 | $253.8 B | 35.9× | 14.9% | +3.9% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
Sources and freshness
- Market cap:
- Oct 13, 2026
- Annual results:
- For year ending December-2025
- Balance sheet:
- As of December-2025
- Employees:
- As of December 31, 2025
- Profile updated:
- Nov 20, 2026
Figures from Market data, SEC filing, value.today research, SEC annual report, GLEIF register; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Senseonics Holdings, Inc.? Verify and update this profile — free
Show Senseonics Holdings, Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.